ID

37003

Descripción

Ibrutinib in Combination With Lenalidomide, With and Without Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02077166

Link

https://clinicaltrials.gov/show/NCT02077166

Palabras clave

Versiones (1)
  1. 27/6/19 27/6/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

27 de junio de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Relapsed Diffuse Large B-Cell Lymphoma NCT02077166

Inglés

Eligibility Relapsed Diffuse Large B-Cell Lymphoma NCT02077166

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologically confirmed relapsed/ refractory dlbcl
Descripción

Diffuse large B-cell lymphoma recurrent | Diffuse large B-cell lymphoma refractory

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0855111
UMLS CUI [2]
C0855112
must have previously received first line treatment regimen
Descripción

First line treatment Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0205156
must be ineligible for high dose therapy/ stem cell transplantation
Descripción

Ineligibility Therapeutic procedure High dose | Ineligibility Stem cell transplant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0444956
UMLS CUI [2,1]
C1512714
UMLS CUI [2,2]
C1504389
measurable disease sites on ct scan (>1.5 cm in longest dimension)
Descripción

Measurable Disease Site CT scan | Measurable Disease Longest Diameter

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1515974
UMLS CUI [1,3]
C0040405
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0552406
pt/inr <1.5 x uln and ptt (aptt) <1.5 x uln
Descripción

Prothrombin time assay | International Normalized Ratio | Activated Partial Thromboplastin Time measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0033707
UMLS CUI [2]
C0525032
UMLS CUI [3]
C0030605
men and women ≥18 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ecog < 2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
adequate hepatic and renal function:
Descripción

Liver function | Renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
1. ast or alt ≤2.5 x uln
Descripción

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
2. creatinine clearance (cockcroft-gault or 24-hour creatinine clearance collection) >60 ml/min.
Descripción

Estimation of creatinine clearance by Cockcroft-Gault formula | 24 hour renal creatinine clearance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2711451
UMLS CUI [2]
C4032392
adequate hematologic function:
Descripción

Hematologic function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0221130
1. anc >1.50 cells/mm3
Descripción

Absolute neutrophil count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
2. plt >75,000 cells/mm3
Descripción

Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
3. hgb >8.0 g/dl
Descripción

Hemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0518015
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
medically apparent central nervous system lymphoma or leptomeningeal disease
Descripción

Central nervous system lymphoma | Leptomeningeal disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0280803
UMLS CUI [2]
C0751297
history of allogeneic stem-cell (or other organ) transplantation
Descripción

Allogeneic Stem Cell Transplantation | Organ Transplantation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2242529
UMLS CUI [2]
C0029216
any chemotherapy, external beam radiation therapy, or anticancer antibodies within 2 weeks
Descripción

Chemotherapy | External Beam Radiation Therapy | Antineoplastic Antibody

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1517033
UMLS CUI [3]
C4329348
radio- or toxin-immunoconjugates within 10 weeks
Descripción

Radioimmunoconjugates | Toxin Immunoconjugates

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0243019
UMLS CUI [2,1]
C0040549
UMLS CUI [2,2]
C0243020
concurrent enrollment in another therapeutic investigational study or have previously taken ibrutinib and/or lenalidomide.
Descripción

Study Subject Participation Status | Therapies, Investigational | Ibrutinib | lenalidomide

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0949266
UMLS CUI [3]
C3501358
UMLS CUI [4]
C1144149
Volver a la parte superior de la página

Similar models

Eligibility Relapsed Diffuse Large B-Cell Lymphoma NCT02077166

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diffuse large B-cell lymphoma recurrent | Diffuse large B-cell lymphoma refractory
Item
pathologically confirmed relapsed/ refractory dlbcl
boolean
C0855111 (UMLS CUI [1])
C0855112 (UMLS CUI [2])
First line treatment Previous
Item
must have previously received first line treatment regimen
boolean
C1708063 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Ineligibility Therapeutic procedure High dose | Ineligibility Stem cell transplant
Item
must be ineligible for high dose therapy/ stem cell transplantation
boolean
C1512714 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,3])
C1512714 (UMLS CUI [2,1])
C1504389 (UMLS CUI [2,2])
Measurable Disease Site CT scan | Measurable Disease Longest Diameter
Item
measurable disease sites on ct scan (>1.5 cm in longest dimension)
boolean
C1513041 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0552406 (UMLS CUI [2,2])
Prothrombin time assay | International Normalized Ratio | Activated Partial Thromboplastin Time measurement
Item
pt/inr <1.5 x uln and ptt (aptt) <1.5 x uln
boolean
C0033707 (UMLS CUI [1])
C0525032 (UMLS CUI [2])
C0030605 (UMLS CUI [3])
Age
Item
men and women ≥18 years of age
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog < 2
boolean
C1520224 (UMLS CUI [1])
Liver function | Renal function
Item
adequate hepatic and renal function:
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
1. ast or alt ≤2.5 x uln
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Estimation of creatinine clearance by Cockcroft-Gault formula | 24 hour renal creatinine clearance
Item
2. creatinine clearance (cockcroft-gault or 24-hour creatinine clearance collection) >60 ml/min.
boolean
C2711451 (UMLS CUI [1])
C4032392 (UMLS CUI [2])
Hematologic function
Item
adequate hematologic function:
boolean
C0221130 (UMLS CUI [1])
Absolute neutrophil count
Item
1. anc >1.50 cells/mm3
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
2. plt >75,000 cells/mm3
boolean
C0032181 (UMLS CUI [1])
Hemoglobin measurement
Item
3. hgb >8.0 g/dl
boolean
C0518015 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Central nervous system lymphoma | Leptomeningeal disease
Item
medically apparent central nervous system lymphoma or leptomeningeal disease
boolean
C0280803 (UMLS CUI [1])
C0751297 (UMLS CUI [2])
Allogeneic Stem Cell Transplantation | Organ Transplantation
Item
history of allogeneic stem-cell (or other organ) transplantation
boolean
C2242529 (UMLS CUI [1])
C0029216 (UMLS CUI [2])
Chemotherapy | External Beam Radiation Therapy | Antineoplastic Antibody
Item
any chemotherapy, external beam radiation therapy, or anticancer antibodies within 2 weeks
boolean
C0392920 (UMLS CUI [1])
C1517033 (UMLS CUI [2])
C4329348 (UMLS CUI [3])
Radioimmunoconjugates | Toxin Immunoconjugates
Item
radio- or toxin-immunoconjugates within 10 weeks
boolean
C0243019 (UMLS CUI [1])
C0040549 (UMLS CUI [2,1])
C0243020 (UMLS CUI [2,2])
Study Subject Participation Status | Therapies, Investigational | Ibrutinib | lenalidomide
Item
concurrent enrollment in another therapeutic investigational study or have previously taken ibrutinib and/or lenalidomide.
boolean
C2348568 (UMLS CUI [1])
C0949266 (UMLS CUI [2])
C3501358 (UMLS CUI [3])
C1144149 (UMLS CUI [4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial